Biotechnology company Moderna has seen its stock price surge following the release of preliminary results from a major clinical trial of its experimental personalized cancer vaccine, marking an important milestone …
This material may not be published, broadcast, rewritten, redistributed or derived from.
Unless otherwise stated, all content is copyrighted © 2025 News Alert.